These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15814706)

  • 1. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells.
    Mead KI; Zheng Y; Manzotti CN; Perry LC; Liu MK; Burke F; Powner DJ; Wakelam MJ; Sansom DM
    J Immunol; 2005 Apr; 174(8):4803-11. PubMed ID: 15814706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolding and characterization of recombinant human soluble CTLA-4 expressed in Escherichia coli.
    Cox GN; Pratt D; Smith D; McDermott MJ; Vanderslice RW
    Protein Expr Purif; 1999 Oct; 17(1):26-32. PubMed ID: 10497065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of exocytosis by cross-linking of the IgE receptor is dependent on ADP-ribosylation factor 1-regulated phospholipase D in RBL-2H3 mast cells: evidence that the mechanism of activation is via regulation of phosphatidylinositol 4,5-bisphosphate synthesis.
    Way G; O'luanaigh N; Cockcroft S
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):63-70. PubMed ID: 10657240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
    Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
    Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation.
    Baroja ML; Luxenberg D; Chau T; Ling V; Strathdee CA; Carreno BM; Madrenas J
    J Immunol; 2000 Jan; 164(1):49-55. PubMed ID: 10604992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4.
    Chikuma S; Murakami M; Tanaka K; Uede T
    J Cell Biochem; 2000 May; 78(2):241-50. PubMed ID: 10842319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.
    Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
    J Immunol; 1998 Oct; 161(8):3919-24. PubMed ID: 9780158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CTLA-4 by human monocytes.
    Wang XB; Giscombe R; Yan Z; Heiden T; Xu D; Lefvert AK
    Scand J Immunol; 2002 Jan; 55(1):53-60. PubMed ID: 11841692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
    Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
    J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
    Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
    J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.
    Chuang E; Alegre ML; Duckett CS; Noel PJ; Vander Heiden MG; Thompson CB
    J Immunol; 1997 Jul; 159(1):144-51. PubMed ID: 9200449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
    Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
    J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continual production of phosphatidic acid by phospholipase D is essential for antigen-stimulated membrane ruffling in cultured mast cells.
    O'Luanaigh N; Pardo R; Fensome A; Allen-Baume V; Jones D; Holt MR; Cockcroft S
    Mol Biol Cell; 2002 Oct; 13(10):3730-46. PubMed ID: 12388770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells.
    Iida T; Ohno H; Nakaseko C; Sakuma M; Takeda-Ezaki M; Arase H; Kominami E; Fujisawa T; Saito T
    J Immunol; 2000 Nov; 165(9):5062-8. PubMed ID: 11046036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-permeable ceramides preferentially inhibit coated vesicle formation and exocytosis in Chinese hamster ovary compared with Madin-Darby canine kidney cells by preventing the membrane association of ADP-ribosylation factor.
    Abousalham A; Hobman TC; Dewald J; Garbutt M; Brindley DN
    Biochem J; 2002 Feb; 361(Pt 3):653-61. PubMed ID: 11802796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
    Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
    Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
    Bulwin GC; Heinemann T; Bugge V; Winter M; Lohan A; Schlawinsky M; Schulze A; Wälter S; Sabat R; Schülein R; Wiesner B; Veh RW; Löhler J; Blumberg RS; Volk HD; Utku N
    J Immunol; 2006 Nov; 177(10):6833-41. PubMed ID: 17082597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.